BARCELONA, SPAIN — High levels of serum probrain natriuretic peptide (proBNP) are associated with an increased risk of macrovascular events, independent of baseline coronary artery disease (CAD) ...
Please provide your email address to receive an email when new articles are posted on . NT-proBNP concentration is a strong predictor of ventricular arrhythmias among people with an implantable device ...
Please provide your email address to receive an email when new articles are posted on . NT-proBNP may predict CV death, incident HF and fatal or nonfatal CV events after acute MI. The association was ...
Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident ...
In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...
March 29, 2009 (Orlando, Florida) — Using individualized levels of the biomarker NT-proBNP to guide the treatment of patients with chronic heart failure did not improve their morbidity or mortality ...
Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...
In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...
The role of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein thought to be a regulator of cardiovascular function) as a robust, non-invasive predictor of cardiovascular risk in patients ...
NT-proBNP testing should become compulsory for referring patients to specialist heart failure services to improve diagnosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results